Programmed cell death-1 blockade enhances response to stereotactic radiation in an orthotopic murine model of hepatocellular carcinoma
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Programmed cell death-1 blockade enhances response to stereotactic radiation in an orthotopic murine model of hepatocellular carcinoma
Authors
Keywords
-
Journal
HEPATOLOGY RESEARCH
Volume 47, Issue 7, Pages 702-714
Publisher
Wiley
Online
2016-08-09
DOI
10.1111/hepr.12789
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- PD-1 Blockade Boosts Radiofrequency Ablation-Elicited Adaptive Immune Responses against Tumor
- (2016) L. Shi et al. CLINICAL CANCER RESEARCH
- Radiotherapy Combined with Novel STING-Targeting Oligonucleotides Results in Regression of Established Tumors
- (2015) J. R. Baird et al. CANCER RESEARCH
- Myeloid cells in hepatocellular carcinoma
- (2015) Shanshan Wan et al. HEPATOLOGY
- The challenge of inoperable hepatocellular carcinoma (HCC): results of a single-institutional experience on stereotactic body radiation therapy (SBRT)
- (2015) Marta Scorsetti et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Survival outcomes after stereotactic body radiotherapy for 79 Japanese patients with hepatocellular carcinoma
- (2015) Hideomi Yamashita et al. JOURNAL OF RADIATION RESEARCH
- Irradiation and anti–PD-L1 treatment synergistically promote antitumor immunity in mice
- (2014) Liufu Deng et al. JOURNAL OF CLINICAL INVESTIGATION
- PD-1 blockade induces responses by inhibiting adaptive immune resistance
- (2014) Paul C. Tumeh et al. NATURE
- Expression of Arginase I in Myeloid Cells Limits Control of Residual Disease after Radiation Therapy of Tumors in Mice
- (2014) Marka R. Crittenden et al. RADIATION RESEARCH
- TGF Inhibition Prior to Hypofractionated Radiation Enhances Efficacy in Preclinical Models
- (2014) K. H. Young et al. Cancer Immunology Research
- Circulating and intratumoral macrophages in patients with hepatocellular carcinoma: correlation with therapeutic approach
- (2013) Pippa Newell et al. AMERICAN JOURNAL OF SURGERY
- The Peripheral Myeloid Expansion Driven by Murine Cancer Progression Is Reversed by Radiation Therapy of the Tumor
- (2013) Marka R. Crittenden et al. PLoS One
- Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Prognostic Factors of Local Control, Overall Survival, and Toxicity
- (2013) Jean-Emmanuel Bibault et al. PLoS One
- Stereotactic Body Radiation Therapy as an Alternative Treatment for Small Hepatocellular Carcinoma
- (2013) Sang Min Yoon et al. PLoS One
- High-dose stereotactic body radiotherapy correlates increased local control and overall survival in patients with inoperable hepatocellular carcinoma
- (2013) Won Il Jang et al. Radiation Oncology
- Increased Frequency of ICOS+ CD4 T Cells as a Pharmacodynamic Biomarker for Anti-CTLA-4 Therapy
- (2013) D. Ng Tang et al. Cancer Immunology Research
- Expression of NF-κB p50 in Tumor Stroma Limits the Control of Tumors by Radiation Therapy
- (2012) Marka R. Crittenden et al. PLoS One
- Stereotactic Hypofractionated Radiation Therapy as a Bridge to Transplantation for Hepatocellular Carcinoma: Clinical Outcome and Pathologic Correlation
- (2011) Alan W. Katz et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Phase I feasibility trial of stereotactic body radiation therapy for primary hepatocellular carcinoma
- (2010) Higinia R. Cárdenes et al. Clinical & Translational Oncology
- Kupffer Cell Suppression of CD8+ T Cells in Human Hepatocellular Carcinoma Is Mediated by B7-H1/Programmed Death-1 Interactions
- (2009) K. Wu et al. CANCER RESEARCH
- Radiotherapy as a bridge to liver transplantation for hepatocellular carcinoma
- (2009) Charbel Sandroussi et al. TRANSPLANT INTERNATIONAL
- A New Population of Myeloid-Derived Suppressor Cells in Hepatocellular Carcinoma Patients Induces CD4+CD25+Foxp3+ T Cells
- (2008) Bastian Hoechst et al. GASTROENTEROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search